Merck's $10B Pulmonary Power Play Is Among Its Top 5 Deals
When Merck agreed to purchase respiratory disease-focused Verona Pharma plc for $10 billion, it became one of Merck's largest deals ever, and the pharmaceutical giant made clear that its bet on...To view the full article, register now.
Already a subscriber? Click here to view full article